The global anal fissure treatment market is expected to attain USD 2.6 Bn and capture a CAGR of 5.2% over the forecast period of 2017-2023. An anal fissure is a painful medical condition where the anal canal has been torn and is accompanied by pain and bleeding during and after defecation. There has been a steep rise in the incidence of anal fissures which is, in turn, propelling the market for anal fissure treatment. The anal fissure market is primarily driven by growing prevalence of constipation, diarrhea, tuberculosis, carcinoma, acquired immunodeficiency syndrome (AIDS), and inflammatory bowel disease, etc. The rise in the geriatric population who are at a higher risk of developing anal fissures owing to decreased blood flow to the anus is also a chief driver of the market. Bad eating habits, leading to stressful and hectic life, and sedentary lifestyle observed among all age groups are even driving the market for anal fissure treatment.
Growing awareness about available treatment options, advancement in drugs and surgical processes such as laser therapy and reduced social stigma associated with its treatment spur the growth of the market. Other drivers include rising cases of tuberculosis, carcinoma, acquired immunodeficiency syndrome (AIDS), inflammatory bowel disease. Additionally, hormonal changes in women during pregnancy cause constipation which results in anal fissures. Childbirth trauma also leads to anal fissures. Other factors include indulgence in anal sex, ulcerative colitis, and Crohn’s disease. Lack of proper reimbursement policy for anal fissure treatment, the risk of incontinence associated with surgery, loss of patents on drugs which result in generic penetration and low returns on investments are a major hindrance to the market.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/3841
Study objectives of Middle East and Africa Anal Fissure Treatment Market:
To provide detailed analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the Middle East and Africa Anal Fissure Treatment Market
To provide insights about factors affecting the market growth in this region
To analyze the Middle East and Africa Anal Fissure Treatment Market based on various factors – price analysis, supply chain analysis, Porters Five Forces analysis etc.
To provide historical and forecast revenue of the market segments and sub-segments with respect to two main geographies and their countries
To provide detailed analysis of the market with respect to the current market size and future prospective
To provide detailed analysis of the market for segments by diagnosis, by treatment, and its sub-segments.
To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Middle East and Africa Anal Fissure Treatment Market.
The global anal fissure treatment market is segmented on the basis of drugs and surgery. Based on drugs, the market has been segmented as topical nitroglycerin, calcium channel blockers, stool softeners, and others. Based on the surgery, the market has been segmented as lateral internal sphincterotomy, anal dilation and others.
US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. The faster market uptake of new technology in the US is also an important driver of the market for global anal fissure treatment. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is the fastest growing region because of large unmet needs which is led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa are expected to be a laggard due to poor economic and political conditions and poor healthcare penetration.
Key players of Global Anal fissure treatment Market:
Key players profiled in the report are SRS Pharmaceuticals Pvt. ltd., Healthy Life Pharma Private Limited, Takeda Pharmaceutical Company Limited, Troikaa Pharmaceuticals Ltd., Novasep, Taj Pharmaceuticals Ltd., PurduePharma L.P., Geri-Care Pharmaceuticals, and others.
Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/3841
Detailed Table of Contents:
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.3 Market Structure:
2 Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research:
3 Market Dynamics
10.1 Key Findings
10.1.1 From Ceo’s Viewpoint
10.1.2 Unmet Needs Of The Market
10.2 Key Companies To Watch
10.3 Prediction Of Anal Fissure Treatment Industry
Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/3841
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Phone: +1 646 845 9312